Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 2/20 | 0.40 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7772772 | 0.86 | RAB9A (0.44) | PDE4BSYKPTPN1RAB9AMAPT | |
| SCHEMBL818901 | 0.86 | RAB9A (0.44) | PDE4BSYKPTPN1RAB9AMAPT | |
| SCHEMBL7772633 | 0.84 | ACHE (0.49) | PDE4BSYKPTPN1RAB9AALDH1A1 | |
| SCHEMBL28630514 | 0.84 | PDE4B (0.39) | PDE4BSYKPTPN1RAB9AMAPT | |
| SCHEMBL1423552 | 0.84 | PTPN1 (0.39) | PDE4BSYKPTPN1RAB9AMAPT | |
| SCHEMBL723314 | 0.84 | PDE4B (0.39) | PDE4BSYKPTPN1RAB9AMAPT | |
| SCHEMBL18362187 | 0.84 | ALDH1A1 (0.45) | PDE4BSYKPTPN1RAB9AMAPT | |
| SCHEMBL7235885 | 0.84 | ACHE (0.49) | PDE4BSYKPTPN1RAB9AALDH1A1 | |
| SCHEMBL16397520 | 0.82 | SYK (0.47) | PDE4BSYKPTPN1RAB9AMAPT | |
| SCHEMBL16406595 | 0.81 | MAPT (0.48) | PDE4BSYKRAB9AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113423742-B | Bis (arylphenoxide) lewis base catalysts and methods thereof | 埃克森美孚化学专利公司 | 2023-05-05 | — | — | CN | disclosed |
| EP-3924395-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2021-12-22 | — | — | EP | disclosed |
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-21 | — | — | US | disclosed |
| CN-113423742-A | Bis (arylphenolate) lewis base catalysts and processes thereof | 埃克森美孚化学专利公司 | 2021-09-21 | — | — | CN | disclosed |
| WO-2020167824-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| US-20200254431-A1 | BIS(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | PHKB, TYR, ELL | PDE4B 3612/4885SYK 361/4885PTPN1 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.